The Food and Drug Administration (FDA) has issued a Class II drug recall for ACME UNITED CORPORATION's Max Packaging Antibacterial Towelette (Benzalkonium Chloride 0.13%), NDC 59647-750-01. The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified by the agency. This action signifies a significant regulatory event for the manufacturer, requiring immediate attention to product removal and corrective actions.

ACME UNITED CORPORATION must manage the recall process, which includes notifying distributors and potentially consumers about the affected product. Compliance officers should verify the scope of distribution and ensure adherence to FDA recall procedures. While specific penalties are not detailed, failure to comply with recall directives can result in further enforcement actions. The recall is marked as 'Ongoing,' indicating that the process is currently active and requires monitoring.